Effect of Myofascial Release Versus Acupressure on Carpal Tunnel Syndrome in Postnatal Period
Launched by CAIRO UNIVERSITY · Jul 18, 2025
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different treatments—myofascial release and acupressure—to see which one works better for women who develop carpal tunnel syndrome (CTS) after giving birth. Carpal tunnel syndrome is a condition that causes pain, numbness, or tingling in the hand and wrist, which can happen when the median nerve is compressed. The study aims to find out which treatment helps relieve these symptoms in new mothers.
Women between the ages of 25 and 35 who have mild to moderate CTS after childbirth may be eligible to join. To qualify, participants need to have specific signs of CTS confirmed by nerve tests and positive results on common physical exams for this condition. Women with other nerve problems, previous wrist surgery, or certain health issues won’t be able to join. If accepted, participants will receive either myofascial release (a type of gentle massage that targets muscle and tissue tightness) or acupressure (applying pressure to specific points on the body) to see which helps reduce their symptoms better. This study is not yet recruiting, so those interested should stay tuned for when enrollment opens.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Postpartum women with mild to moderate carpal tunnel syndrome (CTS).
- • Their ages will range from 25 to 35 years old.
- • Their body mass index (BMI) will range from 25 to 30 Kg/m2.
- • The electrophysiological evidence of mild or moderate median nerve lesion at wrist (mild: sensory nerve conduction velocity slow on finger/wrist measurement, sensory nerve latency \>3.5 ms, normal terminal motor latency; moderate: sensory potential preserved with motor slowing, distal motor latency to abductor pollicis brevis (APB) \< 6.5 ms)
- • Positive phalen's test.
- • Positive tinel's test.
- • Unilateral or bilateral carpal tunnel affection will be included.
- Exclusion Criteria:
- • History of brachial plexopathy or malignancy.
- • Radial, ulnar neuropathy, proximal median neuropathy or polyneuropathy.
- • Previous wrist surgery or steroid injection for CTS.
- • History of trauma, fracture, deformity or inflammation in the wrist, such as rheumatoid arthritis.
- • Coagulation abnormalities, pregnancy, fever and infections.
- • Skin disease and skin cancer.
- • Spots, birthmarks or tattoos over the work points.
- • Pacemaker and implementable medical devices.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Afaf Botla, Professor
Study Director
Cairo University
Soheir El-kosery, Professor
Study Chair
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported